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Multifunctional, Biocompatible, Non-peptidic Hydrogels: from 
Water Purification to Drug Delivery 
Benjamin C. Baker [a]; Clare L. Higgins [a]; Divyashree Ravishankar [b]; Howard M. Colquhoun [a]; Gary C. 
Stevens [c]; Francesca Greco [b]; Barnaby W. Greenland [b] and Wayne Hayes [a]* 
 
Abstract: A novel series of low molecular weight non-peptidic, 
biocompatible super-hydrogelators with both water purification and 
drug delivery properties have been developed. Linking the bis 
aromatic urea groups responsible for gelation together to form bi- 
and tri-armed gelators, affords good control over gelation and water 
purification properties. The use of the gels as effective drug 
scavengers and delivery systems has been demonstrated with dye 
substrates, via pH inversion, as monitored by UV-vis spectroscopy. 
Finally, the systems' abilities as both drug scavenging and delivery 
systems have been demonstrated with the clinically-approved drugs 
chlorpromazine and doxorubicin, respectively. 
Introduction 
Low molecular weight hydrogelators have gained increasing 
interest in recent years as a result of the diverse applicability of 
these systems in areas such as tissue engineering, catalysis 
and electronics.[1,2] Notably, the use of hydrogelators as water 
purification systems has been the focus of several research 
programs.[3-11]  The ability to remove large amounts of toxic 
materials (with respect to toxin:gelator ratio) from aqueous 
systems, makes such systems advantageous in an industrial 
setting.[3-11] 
 
Many reported low molecular weight hydrogelators can entrap 
and gel water at levels of less than 1% by weight of gelator. 
Termed ‘super-gelators’,[12]  such gels are desirable in drug 
delivery systems as they possess the stable rheological 
properties of other gels, but without the need to introduce large 
quantities of organic matter into the final assembly. Stable, low 
molecular weight hydrogelators are finding increasing uses as 
drug delivery systems as a result of their injectibility,[13,14]    
biocompatibility [15,16]  and the ability to control drug release by 
varying the gel’s rheological properties via the concentration of 
gelator). [17-19]   
 
Here we focus on the development of a non-peptidic 
hydrogelating system based on the previously reported gelator 1 
(Figure 1) that was shown to have suitable characteristics for 
water purification and drug delivery.[7,8] Whilst there are 
numerous previous examples of peptide based hydrogelators, 
[13,20,21]   molecules 1 and 3 (Figure 1) represent non-cytotoxic, 
non-peptidic hydrogelators capable of both water purification 
and drug delivery. These non-peptidic gelators have significant 
advantages over peptidic systems in terms of cost, as well as in 
the scalability of their synthesis (for example, hydrogelators 1-3 
are obtained pure (ca. 1g) without recourse to column 
chromatography).  
  
Figure 1. Structures of bis aromatic urea mono and linked hydrogelators 1-3. 
Low molecular weight heteroaromatic dyes were used to 
establish the drug scavenging and delivery capabilities of 
gelators 1-3 (Figure 1). The aromatic moieties present in 1 
enhance this gelator's dye-uptake capabilities via π-π stacking 
and hydrogen bonding interactions.[7-9] Previous studies have 
demonstrated that by combining two of the units to form a linked 
gelator 2 (Figure 1) gelation ability is maintained and dye 
removal efficiency increased. We now report an extension of this 
concept to a tri-armed[22] gelator 3 (Figure 1) with greatly 
improved dye removal capabilities. We also demonstrate the 
abilities of hydrogelators 1-3 to both selectively and 
preferentially remove dyes from solutions containing mixtures of 
dyes. The release of gel-entrapped dyes is achieved via 
adjustments of the pH of the gel medium. Finally we 
demonstrate the potential use of gels 1-3 in the delivery and 
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scavenging of aromatic drug molecules having structures 
complementary to those of the gelating moieties. [23]   
Results and Discussion 
Synthesis and Characterization of Gelators; The aromatic 
ureas 1 and 2 were synthesized according to previously reported 
procedures.[7,9] The tri-urea 3 was synthesized using an 
analogous pathway to that used to generate 2 (see Scheme S1) 
and has been characterized by a combination of spectroscopic 
techniques. The absence of a primary amine resonance in 1H 
NMR spectra of tri-urea 3 indicated successful amide formation 
(see Figure S1-S2). In parallel to this, observation of the 
downfield shifts of the aromatic resonances when compared to 
those of the amine starting material (Scheme S1) showed 
successful formation of the tri-urea 3, as reported in previous 
studies of related molecules.[9]   Further proof of the successful 
synthesis of the tri-urea 3 was provided by IR spectroscopy, with 
the characteristic acyl chloride stretch frequencies (1756 cm-1) 
and amine overtones (3357 cm-1, Figure S3) of the starting 
materials not in evidence in the spectrum of the isolated product. 
The broadened and weakened absorptions associated the 
carboxyl stretches (1658, 1551 cm-1, Figure S4) in comparison 
to the amidic precursor (1728, 1699 cm-1, Figure S3) were 
attributed to the formation of a hydrogen bonded supramolecular 
structure.[24]  Finally formation of the tri-urea gelator 3 was 
confirmed by 13C NMR spectroscopy and mass spectrometric 
analyses. The presence of three key 13C carbonyl resonances 
(at 167.4, 164.5 and 153.2 ppm, Figure S5) and a parent ion in 
the mass spectrum at m/z = 1100.2324 confirmed formation of 
the tri-armed gelator 3 (Figure S6).  
 
Gelation studies; Hydrogels of 1-3 were formed using the well-
documented glucono-δ-lactone protocol, which gave stable, 
transparent gels.  Successful gelation of water using compounds 
1-3 was confirmed via vial inversion tests (the gels being stable 
for > 1 month) and rheological analyses (Table 1, Figure S7), 
which showed that the gels have a storage modulus an order of 
magnitude higher than that of the loss modulus. [7-9]   
  
Table 1. Comparison of the properties of gelators 1-3, Maximum 
storage (G’) and loss moduli (G”) (kPa) for hydrogelators 1-3 each 
at 20 mM. [7,9]    
 
Gelator CGC 
[mM] 
wt % gel G’ (kPa) G” (kPa) ρH (× 
1022/g)[a] 
1 0.9 0.03 294 31.5 1.57 
2 1.8 0.14 327 44.5 1.36 
3 1.8 0.2 250 43.2 1.47 
[a] Density of hydrogen bonding units (× 1022/g)  
  
Compounds 1-3 all exhibited super-gelator characteristics (< 1 
wt% gelator in gel, Table 1). Of particular note are variations in 
the structural stability of the gels. The increase in storage 
modulus (G') of the linked bis-armed gelator 2 when compared 
to that of 1 and 3 suggests differences in the nature of the 
supramolecular assembly that results in gelation. This is in 
agreement with the surfactant-like nature of gelator 2, resulting 
from the hydrophobic nature of the alkyl linker and the polar urea 
end group (see hydrogen bonding units/g values Table 1). 
Moreover, compound 2 shows the ability to thermo-gelate in 
water (a property not demonstrated by gelators 1 and 3). [9]   
Further indications of a different type assembly in gels of 2, 
when compared to those of 1 and 3, were evident from the dye 
absorption properties of the linked gelators and also from toxicity 
studies (see below). 
 
Cytotoxicity testing; To assess the possibility of using 
hydrogelators 1-3 as drug scavengers and delivery vehicles in 
vivo, cytotoxicity testing was undertaken. Using the MTT 
assay[26]   it was found that gelators 1 and 3 were non-toxic at all 
the concentrations tested (0.1-10 μM) whilst 2 was toxic at 
concentrations greater than 1 μM (Figure 2). These data are in 
agreement with the surfactant-like nature of gelator 2, and are in 
accordance with variations seen in assembly methods and dye 
absorption capabilities described previously.[9] To further assess 
the applicability of the gels as drug delivery/scavenging systems 
three individual solutions of gels of 1-3 (1 and 3 1 mL, 20 mM, 2 
1mL, 10 mM) were placed in D2O (10 mL) for 1 month at 37 ˚C 
(Figure S8). Dissolved gelator was not detectable via 1H NMR 
spectroscopic analysis during this period, so it seems that 
gelators in aqueous environments will not present high enough 
concentrations to cause a toxic response with respect to cell 
viability (Figure 2). [27]   
 
Figure 2. Toxicity of gelators 1-3, evaluated using SH-SY5Y (human 
neuroblastoma cell line) to test toxicity, with results monitored via MTT 
assay.[26]   
Dye extraction studies; To analyze the potential of gelators 1-3 
as drug removal and delivery systems aqueous based dyes 
(Figure S9) were employed as model compounds to investigate 
the suitability of each system. Visual analysis of the dye-removal 
capabilities of gels of 1-3 have shown that 3 is by far the most 
efficient for a range of different dyes when compared to gels 
formed by 1 and 2. In each experiment gels (formed at pH 4, 20 
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c) 
b) a) 
Methylene Green 
Methylene Blue 
Direct Red 
Rhodamine B 
mM, 1 mL for 1 and 3, 10 mM, 1mL for 2) formed via glucono-δ-
lactone protocol, were added directly via a spatula to an 
aqueous solution of each respective dye sample (pH 7, 250 mL, 
8 mg L-1) and samples were then removed (0.5 mL) and filtered 
(0.45µm Minisart® syringe filter) for UV/vis spectroscopic 
analysis as in previous studies. [7-9] Dye removal was monitored 
from the decrease in the absorption maximum of each dye and 
then correlated directly to concentration via a calibration curve. 
 
Single dye removal; Previous studies have demonstrated the 
hydrogelator 1 to be an effective scavenger of Methylene Blue, 
Methylene Green and Rhodamine B (Figure 3 a).[7,8]   The 
linkage of two of the moieties responsible for dye absorption, to 
afford gelator 2, has been shown to increase dye uptake 
efficiency,[9]  and interestingly the linked gelator 2 was here 
found to absorb dye when used at concentrations of only 10 mM, 
half the value for gels of 3 and previously reported for gels of 1 
(Figure 3 b).[9] This observation, combined with the surfactant 
like nature of gelator 2 (Figure 1 and 2), highlights possible 
differences in the supramolecular assembly of gels of 2 when 
compared to that of 1 and 3.[7-9] 
 
The dye removal capability of gelator 3 was assessed via UV/vis 
spectroscopic analysis with a range of dye types (Figures 3-4). 
In contrast to gelators 1 and 2, 3 was found to be extremely 
efficient for removal of a range of heteroaromatic dyes and, in 
particular, Methylene Blue, Methylene Green and Direct Red 
showed complete absorption after 5 minutes (each dye solution 
of 250 mL, 8 mg L-1, gelator 3 added at 1 mL, 20 mM) (Figure 3 
c, Figure 4 and Figure S10). The uptake of Methylene Blue by 3 
was determined to be 1450 mg g-1 (dye:gel), a value greater than 
that reported for 1 and 2.[7-9] 
 
 
 
 
 
 
 
 
Figure 3. UV/vis absorption spectra of stirred solutions of aqueous Methylene 
Blue,  Direct Red, Methylene Green and Rhodamine B (250 mL, 8 mg L-1) after 
addition of 1 mL of hydrogelator; a) 1 (1 mL, 20 mM), b) 2 (1 mL, 10 mM) and 
c) 3 (1 mL, 20 mM), and stirring for allotted timeframe. Complete removal of 
Methylene Green and Rhodamine B via gels of 1 were observed only after 3 
days.  
Furthermore the removal of Direct Red, achieved via gelator 3 
(Figure 3 c, Figure 4), was not observed for either gelator 1 or 2 
(a, b Figure 3¸ Table S1). It is proposed that uptake of Direct 
Red occurs as a result of the increased functionality of gelator 3 
enabling increased interactions with the higher molecular weight 
dye (with respect to Methylene Green and Methylene Blue, 
Figure S9), via combinations of hydrogen bonding and π-π 
stacking (vide infra). [7,8,17] 
 
 
 
Figure 4. Removal of single dyes: a) Methylene Blue b) Direct Red c) 
Methylene Green (250 mL, 8 mg L-1): (i) before gelator addition, (ii) after 
addition of hydrogelator 3 (1 mL, 20 mM) and stirring (5 minutes) and (iii) after 
filtration of gelator. 
It is noted that the removal of the dye Rhodamine B did not 
occur with comparable efficiencies to Methylene Blue/Green or 
Direct Red (c, Figure 3) employing gelator 3. Interestingly 
analogous results were not observed using gelator 1 (a Figure 3 
and Figure S11-S12). It is suggested that the carboxylic acid 
moiety of the Rhodamine B dye competitively binds to the 
carboxylic functionalized gelator 3 to hinder effective fibril 
formation and so diminish dye uptake (Figure S9).[7,8,9] Such 
results were not seen with the mono-armed gelator 1, which 
relies on hydrogen bonding nitro-urea interactions to effectively 
form a stable gel.[7] 
 
To understand the binding motifs underpinning the dye uptake 
by gelator 3, dilution studies using 1H NMR spectroscopy were 
undertaken on samples of the gelator and dyes Rhodamine B 
and Methylene Blue (a and b, respectively, see Figure 5). 
Spectra were acquired in the dipolar aprotic solvent DMSO-d6 to 
avoid gelation during the NMR study. Of note, and apparent in 
both studies, is the splitting of the resonances associated with 
the central core aromatic moieties in gelator 3 with increasing 
dye concentration (see H8, Figure 5). It is proposed that such 
splitting arises from the presence of unbound and bound gelator 
(with respect to the dye), implying slow exchange on the NMR 
timescale. [28,29]  The multiplicity and chemical shift of resonances 
associated with the urea protons of the gelator (H3-4 Figure 5) 
also indicate a breakdown in the intermolecular hydrogen 
bonding interactions between the gelator molecules and an 
increase in those between gelator and dye, suggesting that this 
is a key interaction for dye absorption, facilitating dye removal in 
aqueous solvents yet resulting in shortening in fibril structure 
and gel weakening as is noted in previous studies (vide infra).[7-
9,27,30] Finally, shifts in the resonances associated with linking 
and terminal aromatic rings  
 
 
a) c) b) 
i) ii) iii) i) ii) iii) i) ii) iii) 
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(H1-2,5-6 in Figure 5) in both dilution studies suggests π-π 
stacking is an additional driving force behind dye absorption in 
the gel, as reported in equivalent studies on gelators 1 and 2.[7-9] 
 
Differences to note include the level of dye loading (with respect 
to gelator) necessary to produce the same shifts of the gelator 
urea, amide and central core resonances when comparing the 
two dyes. In studies of binding between gelator and Rhodamine 
B, splitting of the central core aromatic resonance (H8 Figure 5) 
was observed at a molar ratio of 6:1 (gelator:dye), with gelator 
urea resonances (H3-4 Figure 5) appearing at a ratio of 4:1.  In 
analogous binding studies of the gelator with Methylene Blue, 
splitting of the central core aromatic resonance was not 
observed until a molar ratio of 1:4 (gelator:dye) was reached, 
and urea resonances did not appear until a molar ratio of 1:6 
was achieved.  Such a large increase in the level of dye needed 
to implement such changes in the spectra reflects the increased 
efficiency of the gelator to bind to Methylene Blue dye when 
compared with Rhodamine B (directly related to dye removal 
studies in aqueous environments). Indeed, the efficiency of dye-
gelator binding is such that at a molar ratio of 1:8 ratio 
(gelator:dye) free Rhodamine B dye was not detectable by 1H 
NMR spectroscopic analysis (Figure 5b).  
 
In attempts to understand the differences in efficiency of the dye 
uptake of Rhodamine B and Methylene Blue by gelator 3, shifts 
in comparable proton resonances were analyzed. No significant 
differences were observed in the amide and urea shifts (H7 and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H3-4, respectively, Figure 5), but analysis of the terminal aromatic 
resonances (H1-2 Figure 5) demonstrated a much larger shift with 
Methylene Blue than with Rhodamine B. Attempts to analyze 
linker aromatic shifts (H5-6 Figure 5) were complicated by gel/dye 
resonance overlap. It is suggested that increased π-π stacking 
interactions between the gelator and Methylene Blue when 
compared to Rhodamine B is the driving force behind increased 
efficiency of uptake of the former dye.[7-9] 
 
Small angle X-ray scattering (SAXS) analysis of gels of 3 both 
before and after Methylene Blue absorption were undertaken to 
further ascertain method of dye removal. Prior to dye absorption, 
no significant scattering was observed (Figure S13), consistent 
with the amorphous nature of the gel. However, after dye 
absorption, small-angle scattering was observed corresponding 
to a d-spacing of approximately 300 Å (Figure S14). It has been 
suggested in the literature that such scattering occurs as a result 
of the intercalation of the dye into the fibrils of the gelator, 
disrupting the fibrils assembly and thus length due to the 
increased propensity for disassociation from the gel bulk 
resulting in detection (as noted in other dye absorption studies 
on gels of 1).[7,8] 
 
Finally it is noted that absorption studies of gelators 1-3 with the 
azide functionalized dye Direct Orange each showed no 
significant dye removal, highlighting the need for the structure of 
the dye to resemble that of the gelator for successful removal. 
Figure 5. a) 1H NMR spectra of hydrogelator 3 and Rhodamine B (* denoting resonances associated with the dye, in non-gelling solvent DMSO-d6) where 
the bottom spectrum is pure 3, and top is pure Rhodamine B (mixtures 8:1, 6:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:4, in ascending order, mol:mol, 3:Rhodamine B); b) 
1H NMR spectra of hydrogelator 3 and Methylene Blue (▲ denoting resonances associated with the dye, in non-gelling solvent DMSO-d6) where the bottom 
spectrum is pure 3, top is pure Methylene Blue (mixtures 1:2, 1:4, 1:6, 1:8, 1:10, 1:12, in ascending order, mol:mol, 3:Methylene Blue). 
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This proved important in the sequential dye-removal studies 
reported below.[7] 
 
Sequential dye removal; It was decided to compare the most 
versatile dye removal gelators 1 and 3 (Figure 3) in selective dye 
removal studies. Primarily the effect of the comparison of 
selective removal of Methylene Blue from mixtures of Direct 
Orange and Methylene Blue (250 mL H2O, 4 mg L-1, 1:1 wt% 
dye) was studied in both gelators (1mL, 20 mM). It was found 
that both gelators were able to successfully remove the 
Methylene Blue from the solution of mixed dyes (Figure 6 and 
Figure S15). The presence of the non-absorbed Direct Orange 
did not have an effect on the uptake efficiency of gelators 1 or 3 
(Figure 6 b) for Methylene Blue. 
 
 
 
 
 
 
 
 
 
Figure 6. Selective removal of Methylene Blue from Methylene Blue:Direct 
Orange aqueous solution (250 mL, 4 mg L-1, 1:1 % wt dye) after addition of 1 
mL of hydrogelator 1 or 3 (1 mL, 20 mM) where; a) i) Methylene Blue:Direct 
Orange solution, ii) after addition of gel of 3 and five minutes stirring, iii) after 
filtration of gel, b) percentage absorption of dyes after addition of 
hydrogelators 1 and 3 (1 mL, 20 mM). 
In a further selectivity experiment, the absorption capabilities of 
gelators 1 and 3 (1 mL, 20 mM) in mixtures of  Direct 
Red/Methylene Blue aqueous solutions (250 mL, 4 mg L-1, 1:1 % 
wt dye) were compared. Gelator 3 successfully removed both 
dyes from solution, although the rate of removal was effectively 
halved, now taking 10 minutes for complete dye removal (Figure 
7 and Figure S16). It was observed that in the removal of 
Methylene Blue, Gelator 1 was hindered in presence of the 
Direct Red (Figure 7 and Figure S16), indeed subsequent 
release of the dyes after 30 minutes stirring was observed. This 
observation supports the hypothesis that the density of 
functional groups capable of supramolecular interactions within 
the gelator has a direct effect on its dye removal capabilities. 
 
 
 
Figure 7. Absorption of Methylene Blue and Direct Red from a mixed aqueous 
solution (250 mL, 4 mg L-1, 1:1 wt% dye) after addition of 1 mL of 
hydrogelators 1 or 3 (1 mL, 20 mM). 
The rate of dye removal by gelator 3 was further demonstrated 
by preferential dye removal experiments. Rhodamine B and 
Methylene Blue were selected in combination as a result of the 
variation in absorption rates (Figure 3 c). The dyes were mixed 
in a wt/wt ratio of 1:1 (250 mL, 4 mg L-1) and gelator 3 was 
added (1 mL, 20 mM) as in previous examples. Preferential 
absorption of Methylene Blue was shown (99% absorbed, Figure 
8 c) in comparison to Rhodamine B (5% absorbed, Figure 8c) 
(Figure S17). The presence of Rhodamine B had no impact on 
the rate of Methylene Blue absorption, with this dye being 
removed completely after 5 minutes. Interestingly it was found 
that the remaining Rhodamine B was absorbed after addition of 
a larger volume of gelator 3 to the mixture (3 mL, 20 mM) 
(Figure 8 and Figure S17), but at a decreased rate with respect 
to gelator:dye volume (see Figure 3 for a comparison). 
 
 
 
 
 
 
 
 
Figure 8. a) Preferential removal of Methylene Blue from Methylene 
Blue:Rhodamine B aqueous solution (250 mL, 4 mg L-1, 1:1 % wt dye) (see i) 
after addition of 1 mL of hydrogelator 3 (1 mL, 20 mM) (see ii) and filtration 
(see iii)  b) removal of Rhodamine B from same mixture as b (see i) after 
second addition of hydrogelator 3 (3 mL, 20 mM) (see ii) and filtration (see iii), 
c) percentage absorption showing same selective dye removals as a and b.  
In order to explore the possibilities of pH-induced molecular 
release, a process relevant to drug delivery and gel 
regeneration,[2,18,31] the release of absorbed Methylene Blue via 
pH variation was studied with gelators 1-3. The gelator and 
aqueous dye solutions were prepared as in previous 
experiments, and the dye was absorbed onto the gelator from 
solution. The pH of the solution was varied by addition of either 
NaOH(s) or HCl(conc) to minimise volume and concentration 
variation. The pH was varied between 7 and 9 to effect dye 
adsorption and release. 
 
It was observed that upon raising the pH to 9, breakdown of the 
gel structure (leading to dissolution and dilution of the gelators in 
the bulk solvent) allowed release of absorbed Methylene Blue 
(Figure 9). Using the ratios derived from dilution studies (see 
Figure S18) the percentage release of dye at a given pH could 
b) a) 
i) ii) iii) 
a) b) 
c) Addition of 
secondary vial of 
gelator 3 
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be calculated for each gelator. It was apparent that gelator 2 
releases the dye at the fastest rate, with 100% release being 
achieved in less than 2 hours (Figure 9, Figure S19). However, it 
is noted that the gels of this system are formed at half the 
concentration of 1 and 3 as a result of the different assembly 
and absorption properties of 2. Gels of 1 and 3 showed slower 
release of Methylene Blue, with 3 achieving a higher final level 
(90%) of release than 1 (60%). 
 
Figure 9. Percentage release of Methylene Blue dye from gels of 1-3 (for 1 
and 3 1 mL, 20 mM, for 2 1 mL, 10 mM) into NaOH(aq) (pH 9, 250 mL) after 
Methylene Blue (250 mL, 4 mg L-1) has been absorbed onto gelators. 
The versatility of gelator 3, in terms of dye removal/release was 
also demonstrated via multiple absorption/release cycles (Table 
2 and Figure S20). As is shown the cycles have minimal impact 
on the ability of the gelator to absorb/release dyes effectively. 
  
Table 2. Percentage absorption and 
release of Methylene Blue dye via pH 
switching of a solution containing 
Methylene Blue (250 mL, 8 mg L-1) 
and gelator 3 (1 mL, 20 mM). 
Gelator CGC 
[mM] 
wt % gel 
1 0.9 0.03 
2 1.8 0.14 
3 1.8 0.2 
[a] Density of hydrogen bonding units 
(× 1022/g) 
  
Drug scavenging and delivery; To assess the possibility of the 
use of the gelators as drug removal motifs from aqueous 
solution 3 was selected as the model system, being the most 
efficient gelator for dye-removal (see Figures 3, 6 and 7) and 
non-cytotoxic (Figure 2). Chlorpromazine was chosen as a 
model drug, as a result of its structural similarity to Methylene 
Blue (Figure S21), and its toxic effects at high dosage.[32] It was 
found that gels of 3 were able to remove the drug efficiently from 
D2O in 10 minutes, as monitored via 1H NMR spectroscopy 
(Figure 10), using the same removal protocols as those 
described previously. 
 
Figure 10. 1H NMR spectra showing removal of chlorpromazine (CP) from 
D2O. Top: chlorpromazine 8 mg/ml (25 mL) spiked with ethanol as a reference 
(10 μm). Bottom: sample after stirring with gel of 3 (1 mL, 20 mM) for 10 
minutes. 
Based upon the mechanical stability (Table 1), non-cytotoxicity 
(Figure 2) and release duration (Figure 9) hydrogelator 1 was 
selected as a model system to investigate drug release via 
diffusion over the other two gelators. The system also 
demonstrates gel re-formation properties after disruption and 
injection suitable for drug delivery (recovery of storage 
modulus[7] achievable 5 minutes after injection and vial inversion 
stability after 20 minutes Figure S22-3), not released in either of 
the other two gelators. Doxorubicin was selected as the drug for 
delivery after it was ascertained that drug release would not be 
hindered via intercalation into the gel fibrils and hence 
reabsorption (monitored via UV/vis spectra readings under same 
method as dye uptake, gel of 1, 1mL 20mM being placed into a 
stirred solution of doxorubicin 10 mL 0.1 mg/mL) (attributed to 
the dissimilarity between the drug and previously mentioned 
dyes, Figures S9 and S21).  
 
Two gel samples were prepared via dissolution of gelator 1 (20 
mM and 80 mM) in NaOH(aq) (0.01 M, 0.5 mL). Doxorubicin (0.2 
mL, 0.1 mg/mL) was introduced via dilution in HCl(aq) (0.02 M, 
0.3 mL) and addition to gelator 1 NaOH(aq) solution to achieve 
gelation. The gels were then injected into phosphate buffer 
saline solution and held at 37 ˚C over a period of 1 month. Drug 
release was monitored via UV/vis spectroscopic analysis, 
correlating the absorption maxima of doxorubicin (485 nm) with 
percentage release, as in the dye-release studies described 
above.  
 
Gelator 1 proved to be an effective release system, and the rate 
of release was controllable via gelator concentration (Figure 11 
CP 
CP 
CP 
CP 
D2O 
D2O 
EtOH 
EtOH 
EtOH 
EtOH 
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and Figures S24 - S25).[7,17-19,33]  At both gelator concentrations, 
a burst release was observed within the first 24 hours (the level 
of release directly related to gelator concentration), after which 
Fickian-like delivery predominated at both concentrations. [17-19,33] 
Finally, plateauing was recorded in both concentrations when 
drug delivery exceeded 90%.  
 
Figure 11. Release of doxorubicin (0.02 mg) from gelator 1 (at concentrations 
of 20 mM and 80 mM, 1 mL) into phosphate buffer saline solution. 
Conclusions 
It has been demonstrated that a range of hydro-super-gelators 
can be synthesised with a bis aromatic urea motif. These super-
gelators have demonstrated significant water purification 
properties via gelator-impurity (dye) binding. Linking the motifs 
responsible for binding creates a significant improvement on the 
ability of the resulting gels to purify water. The ability of such 
gels to preferentially and sequentially remove species from 
aqueous environments has been demonstrated. It has also been 
demonstrated that absorbed species contained within the 
formed gels can be released by pH switching.  
 
Furthermore it has been demonstrated that the tris armed 
gelator can effectively remove model drug compounds from 
aqueous solutions.  The mono armed gelator 1 can also 
successfully release model drugs via diffusion, with release 
rates controllable via the concentration of the formed gelators.  
Combined with the biocompatibility of the two hydrogelators 1 
and 3, and injectability of the mono gelator 1 it is suggested that 
they would be suitable as both drug-release and drug-
scavenging agents.  
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Herein we describe the synthesis and properties of three generations of low 
molecular weight non-peptidic super hydrogelators. These non-cytotoxic super 
hydrogelators exhibit both water purification and drug delivery properties via the 
controlled uptake of aromatic based dyes and release of the clinically-approved 
drugs chlorpromazine and doxorubicin. 
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